Elizabeth Czerepak
2013 - Cancer Genetics
In 2013, Elizabeth Czerepak earned a total compensation of $494.8K as Chief Financial Officer at Cancer Genetics, a 52% increase compared to previous year.
Compensation breakdown
| Bonus | $220,000 |
|---|---|
| Salary | $250,000 |
| Other | $24,759 |
| Total | $494,759 |
Czerepak received $250K in salary, accounting for 51% of the total pay in 2013.
Czerepak also received $220K in bonus and $24.8K in other compensation.
Rankings
In 2013, Elizabeth Czerepak's compensation ranked 9,397th out of 12,286 executives tracked by ExecPay. In other words, Czerepak earned more than 23.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,397 out of 12,286 | 24th |
Division Services | 1,505 out of 1,938 | 22nd |
Major group Health Services | 153 out of 198 | 23rd |
Industry group Medical And Dental Laboratories | 34 out of 49 | 31st |
Industry Medical Laboratories | 34 out of 49 | 31st |
Source: SEC filing on April 21, 2014.
Czerepak's colleagues
We found two more compensation records of executives who worked with Elizabeth Czerepak at Cancer Genetics in 2013.